Thomas Noll

Title: Innovations of Thomas Noll in Recombinant Production

Introduction

Thomas Noll is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein production. His innovative methods have the potential to enhance the efficiency of polypeptide production in eukaryotic host cells.

Latest Patents

Thomas Noll holds 1 patent for a method that describes the recombinant production of a polypeptide in a modified eukaryotic host cell. This method involves cultivating the host cell in a suitable medium while maintaining the dissolved CO (pCO) content in the medium at a constant value between 10% and 20%. This innovation is crucial for optimizing the expression of the desired polypeptide.

Career Highlights

Throughout his career, Thomas Noll has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work has contributed to advancements in the production of therapeutic proteins, which are essential for various medical applications.

Collaborations

Thomas has collaborated with esteemed colleagues such as Alexander Jockwer and Jochen Gaetgens. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

In summary, Thomas Noll's contributions to recombinant production methods represent a significant advancement in biotechnology. His innovative approach has the potential to improve the efficiency of polypeptide production, benefiting the pharmaceutical industry and beyond.